Autologous umbilical cord blood mononuclear cell therapy for hypoplastic left heart syndrome: a nonrandomized control trial of the efficacy and safety of intramyocardial injections

Guardado en:

Detalles Bibliográficos
Publicado en:	Stem Cell Research & Therapy vol. 16, no. 1 (Dec 2025), p. 215
Autor principal:	Gallego-Navarro, Carlos
Otros Autores:	Jaggers, James, Burkhart, Harold M., Carlo, Waldemar F., Morales, David L., Qureshi, M. Yasir, Rossano, Joseph W., Hagen, Clinton E., Seisler, Drew K., Peral, Susana Cantero, Nelson, Timothy J.
Publicado:	Springer Nature B.V.
Materias:	Mayo Clinic University of Oklahoma Food & Drug Administration > FDA Minnesota Colorado United States > US Los Angeles California Oklahoma Enrollments Physiology Clinical trials Umbilical cord Heart diseases Congenital diseases Births Manufacturing Troponin T Statistical analysis Guardians Stem cells Myocardium Cell therapy Preservation Good Manufacturing Practice Surgery FDA approval Biomarkers Palliation Adverse events Cardiovascular disease Troponin Regenerative medicine Hospitals Muscle contraction Bone marrow Heart Leukocytes (mononuclear) Safety Ventricle Patients Cord blood Cardiac function
Acceso en línea:	Citation/Abstract Full Text Full Text - PDF
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!